From: Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement
Characteristics | HIT Ab(-) n = 68 | HIT Ab(+) n = 36 | p-value |
---|---|---|---|
Age (years), mean (SD) | 68.5 ± 11.8 | 66.9 ± 12.3 | 0.50 |
Gender (male/female) | 13/55 | 4/32 | 0.29 |
BMI (Kg/m2), mean (SD) | 24.62 ± 4.31 | 25.71 ± 4.42 | 0.29 |
Metabolic diseases, n(%) | 30(44.1%) | 13(36.1%) | 0.43 |
Hypertension | |||
Diabetes | |||
Hyperlipidemia | |||
History of thrombosis | - | 1(2.8%) | - |
TKA/THA | 27/41 | 17/19 | 0.46 |
Primary disease | 14/54 | 4/32 | 0.19 |
(RA/OA) |